V. Kansara

发表

In vitro transport and partitioning of AL-4940, active metabolite of angiostatic agent anecortave acetate, in ocular tissues of the posterior segment.

A. Mitra, U. Kompella, S. Duvvuri, 2010, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats.

A. Mitra, S. Duvvuri, N. Mandava, 2007, International journal of pharmaceutics.

The Hierarchy of Proinflammatory Cytokines in Ocular Inflammation

T. L. McGee, C. Bigelow, A. D. da Cunha, 2018, Current eye research.

Application of Imaging Mass Spectrometry to Assess Ocular Drug Transit

M. Mogi, P. Rudewicz, V. Kansara, 2017, SLAS discovery : advancing life sciences R & D.

Identification and functional characterization of riboflavin transporter in human-derived retinoblastoma cell line (Y-79): mechanisms of cellular uptake and translocation.

A. Mitra, D. Pal, R. Jain, 2005, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Folic acid transport via high affinity carrier-mediated system in human retinoblastoma cells.

A. Mitra, Ripal Gaudana, V. Kansara, 2008, International journal of pharmaceutics.

Suprachoroidal delivery enables targeting, localization and durability of small molecule suspensions.

T. Ciulla, V. Kansara, Shelley E Hancock, 2022, Journal of controlled release : official journal of the Controlled Release Society.

Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug delivery.

A. Mitra, Xiaodong Zhu, N. Mandava, 2006, Molecular pharmaceutics.

Biotin uptake and cellular translocation in human derived retinoblastoma cell line (Y-79): a role of hSMVT system.

A. Mitra, D. Pal, V. Kansara, 2006, International journal of pharmaceutics.

Activity of a sodium-dependent vitamin C transporter (SVCT) in MDCK-MDR1 cells and mechanism of ascorbate uptake.

A. Mitra, D. Pal, V. Kansara, 2008, International journal of pharmaceutics.

Vitreal pharmacokinetics of dipeptide monoester prodrugs of ganciclovir.

S. Majumdar, A. Mitra, V. Kansara, 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Dipeptide monoester ganciclovir prodrugs for transscleral drug delivery: targeting the oligopeptide transporter on rabbit retina.

A. Mitra, V. Kansara, Yi Hao, 2007, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Evaluation of an Ex Vivo Model Implication for Carrier-Mediated Retinal Drug Delivery

A. Mitra, Viral Kansara, Ashim K Mitra, 2006, Current eye research.

High-Throughput Melanin-Binding Affinity and In Silico Methods to Aid in the Prediction of Drug Exposure in Ocular Tissue.

Sarah L. Williams, M. Serrano-Wu, J. Reilly, 2015, Journal of pharmaceutical sciences.

Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular Diseases

T. Ciulla, C. Wan, V. Kansara, 2021, Pharmaceutics.

Injectable Lipid Emulsions—Advancements, Opportunities and Challenges

S. Majumdar, Ketan Hippalgaonkar, Soumyajit Majumdar, 2010, AAPS PharmSciTech.

Anti-integrin therapy for retinovascular diseases

A. Bhatwadekar, T. Ciulla, V. Kansara, 2020, Expert opinion on investigational drugs.

Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in Rabbits

T. Ciulla, V. Kansara, L. Muya, 2021, Translational vision science & technology.

Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease

A. Harris, T. Ciulla, V. Kansara, 2019, Expert opinion on investigational drugs.

Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases

T. Ciulla, C. Wan, V. Kansara, 2020, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Suprachoroidal Injection of Triamcinolone Acetonide Suspension: Ocular Pharmacokinetics and Distribution in Rabbits Demonstrates High and Durable Levels in the Chorioretina

M. Cavet, T. Ciulla, V. Kansara, 2022, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Discovery of Highly Potent and Selective Small-Molecule Reversible Factor D Inhibitors Demonstrating Alternative Complement Pathway Inhibition in Vivo.

Karen Anderson, Anna Vulpetti, Ulrich Hommel, 2017, Journal of medicinal chemistry.

Investigational plasma kallikrein inhibitors for the treatment of diabetic macular edema: an expert assessment

A. Bhatwadekar, T. Ciulla, V. Kansara, 2020, Expert opinion on investigational drugs.

Suprachoroidal CLS-AX (axitinib injectable suspension), as a Potential Long-Acting Therapy for Neovascular Age-Related Macular Degeneration (nAMD)

P. Kaiser, T. Ciulla, V. Kansara, 2020 .

Suprachoroidally Delivered DNA Nanoparticles Transfect Retina and Retinal Pigment Epithelium/Choroid in Rabbits

R. Moen, T. Ciulla, V. Kansara, 2020, Translational vision science & technology.

Long-acting protein drugs for the treatment of ocular diseases

T. Dryja, B. Jaffee, C. Bigelow, 2017, Nature Communications.

Pharmacokinetics and Ocular Tolerability of Suprachoroidal CLS-AX (axitinib injectable suspension) in rabbits

T. Ciulla, V. Kansara, L. Muya, 2020 .